Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comment on: 'One-year real-world outcomes in patients receiving fixed-dosing aflibercept for neovascular age-related macular degeneration'.

Literature DB >> 29026187

Comment on: 'One-year real-world outcomes in patients receiving fixed-dosing aflibercept for neovascular age-related macular degeneration'.

A R Nestel¹.

Abstract

Entities: Species

Mesh：

Substances：

Year: 2017 PMID： 29026187 PMCID： PMC5811725 DOI： 10.1038/eye.2017.211

Source DB: PubMed Journal: Eye (Lond) ISSN： 0950-222X Impact factor: 3.775

Keyword Cloud
References

× No keyword cloud information.

2 in total

1. One-year real-world outcomes in patients receiving fixed-dosing aflibercept for neovascular age-related macular degeneration.

Authors: H Almuhtaseb; S Kanavati; S R Rufai; A J Lotery
Journal: Eye (Lond) Date: 2017-02-10 Impact factor: 3.775

2. Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial.

Authors: Usha Chakravarthy; Simon P Harding; Chris A Rogers; Susan M Downes; Andrew J Lotery; Sarah Wordsworth; Barnaby C Reeves
Journal: Ophthalmology Date: 2012-05-11 Impact factor: 12.079

2 in total